Chloroplasts (magenta color) in leaves expressing a green fluorescent protein. The DNA encoding for the protein was delivered by targeted nanomaterials without mechanical aid by applying a droplet of the nano-formulation to the leaf surface. (Israel Santana/UCR)
The future of vaccines may look more like eating a salad than getting a shot in the arm. UC Riverside scientists are studying whether they can turn edible plants like lettuce into mRNA vaccine factories.
Messenger RNA or mRNA technology, used in COVID-19 vaccines, works by teaching our cells to recognize and protect us against infectious diseases.
One of the challenges with this new technology is that it must be kept cold to maintain stability during transport and storage. If this new project is successful, plant-based mRNA vaccines — which can be eaten — could overcome this challenge with the ability to be stored at room temperature.
The project’s goals, made possible by a $500,000 grant from the National Science Foundation, are threefold: showing that DNA containing the mRNA vaccines can be successfully delivered into the part of plant cells where it will replicate, demonstrating the plants can produce enough mRNA to rival a traditional shot, and finally, determining the right dosage.
“Ideally, a single plant would produce enough mRNA to vaccinate a single person,” said Juan Pablo Giraldo, an associate professor in UCR’s Department of Botany and Plant Sciences who is leading the research, done in collaboration with scientists from UC San Diego and Carnegie Mellon University.
“We are testing this approach with spinach and lettuce and have long-term goals of people growing it in their own gardens,” Giraldo said. “Farmers could also eventually grow entire fields of it.”
Key to making this work are chloroplasts — small organs in plant cells that convert sunlight into energy the plant can use. “They’re tiny, solar-powered factories that produce sugar and other molecules which allow the plant to grow,” Giraldo said. “They’re also an untapped source for making desirable molecules.”
In the past, Giraldo has shown that it is possible for chloroplasts to express genes that aren’t naturally part of the plant. He and his colleagues did this by sending foreign genetic material into plant cells inside a protective casing. Determining the optimal properties of these casings for delivery into plant cells is a specialty of Giraldo’s laboratory.
For this project Giraldo teamed up with Nicole Steinmetz, a UC San Diego professor of nanoengineering, to utilize nanotechnologies engineered by her team that will deliver genetic material to the chloroplasts.
“Our idea is to repurpose naturally occurring nanoparticles, namely plant viruses, for gene delivery to plants,” Steinmetz said. “Some engineering goes into this to make the nanoparticles go to the chloroplasts and also to render them non-infectious toward the plants.”
For Giraldo, the chance to develop this idea with mRNA is the culmination of a dream. “One of the reasons I started working in nanotechnology was so I could apply it to plants and create new technology solutions. Not just for food, but for high-value products as well, like pharmaceuticals,” Giraldo said.
Giraldo is also co-leading a related project using nanomaterials to deliver nitrogen, a fertilizer, directly to chloroplasts, where plants need it most.
Nitrogen is limited in the environment, but plants need it to grow. Most farmers apply nitrogen to the soil. As a result, roughly half of it ends up in groundwater, contaminating waterways, causing algae blooms, and interacting with other organisms. It also produces nitrous oxide, another pollutant.
This alternative approach would get nitrogen into the chloroplasts through the leaves and control its release, a much more efficient mode of application that could help farmers and improve the environment.
Original Article: Grow and eat your own vaccines?
More from: University of California Riverside | Carnegie Mellon University
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
mRNA factories
- Moderna Stock (NASDAQ:MRNA), Quotes and News Summaryon May 2, 2024 at 12:22 pm
Major index futures point to a positive open on Thursday. Shanthi Rexaline mRNA Is Promising A Breakthrough In Fighting Cancer When it comes to cancer, there’s innovation both on the diagnostics ...
- Moderna (MRNA) Q1 2024 Earnings Call Transcripton May 2, 2024 at 9:30 am
Welcome to the Moderna's first-quarter 2024 conference call. [Operator instructions] Please be advised, today's conference is being recorded. I would now like to hand the conference over to your ...
- Egypt inaugurates BioGeneric Pharma factory to produce mRNA vaccines, biologicson May 1, 2024 at 5:00 pm
The factory consists for three main units for the ... South Africa and Tunisia will receive vaccine manufacturing support from the WHO’s mRNA technology transfer hub. The African countries ...
- Moderna (MRNA) Gears Up for Q1 Earnings: Here's What to Expecton April 29, 2024 at 8:33 am
Investors' focus will likely be on updates on Moderna's (MRNA) expected RSV vaccine launch and its late-stage pipeline candidates when it reports first-quarter earnings.
- China's drugmakers can't sell mRNA shots but haven't quit yeton April 19, 2024 at 12:31 am
China's vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are pursuing new targets for the novel messenger RNA technology, but they face a tough path, crimped by a ...
Go deeper with Google Headlines on:
mRNA factories
[google_news title=”” keyword=”mRNA factories” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Plant-based mRNA vaccines
- MRNA vaccine effective in treating glioblastoma brain cancer in small trialon May 2, 2024 at 9:24 am
An experimental cancer vaccine can quickly reprogram a person's immune system to attack glioblastoma, the most aggressive and lethal form of brain cancer, a small, preliminary study has found.
- New mRNA Vaccines in Development for Cancer and Infectionson May 2, 2024 at 2:22 am
Prelog also discussed personalized vaccines for cancer immunotherapy. Personalized mRNA vaccines are tailored to the patient's genetic characteristics and antigens. They could be used in cancer ...
- Brain cancer in children is notoriously hard to treat – a new mRNA cancer vaccine triggers an attack from withinon May 1, 2024 at 8:01 am
Cancer vaccines have gained much interest among scientists but face a number of hurdles. A new mRNA vaccine for glioma offers a step forward in training the immune system to fight cancer.
- Why Africa is facing an uphill battle to make its own vaccineson May 1, 2024 at 6:30 am
The continent – in dire need of its own production capabilities – could once again be at the back of the vaccine queue in the next pandemic ...
- Africa CDC blasts Moderna after it halts plans to build vaccine plant in Kenyaon April 17, 2024 at 3:28 am
The Africa CDC responded to Moderna’s plans to step back from building a mRNA vaccine manufacturing ... build a $500 million plant because it hasn’t received any vaccine orders from the ...
Go deeper with Google Headlines on:
Plant-based mRNA vaccines
[google_news title=”” keyword=”plant-based mRNA vaccines” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]